Skip to main content
. 2024 Jul 12;11(7):710. doi: 10.3390/bioengineering11070710

Figure 12.

Figure 12

Roseburia abundance (a) and intestinal permeability (b) trends over Vedolizumab concentration in central blood compartment, as predicted by the model and derived from the clinical study (dots).